Efficacy and safety of neoadjuvant dual anti-HER2 therapy in older patients with HER2-positive breast cancer: A real-world retrospective analysis

Journal of Geriatric Oncology 2026

View at publisher

Authors: L.S.J. Au, Y.N. Zhang, K. Yeung, K.L. Cheung, W.L. CHAN

DOI: 10.1016/j.jgo.2026.102883

Cited by: 0

Fields of Study & Subjects

HER2/EGFR in Cancer Research Breast Cancer Treatment Studies Gastric Cancer Management and Outcomes